Curative brachytherapy for recurrent/residual tongue cancer

Strahlentherapie und Onkologie

Volumn 183, Issue 3, 2007, Pages 133-137

  Ayukawa, Fumio ^a   Shibuya, Hitoshi ^b   Yoshimura, Ryo Ichi ^b   Watanabe, Hiroshi ^b   Miura, Masahiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Brachytherapy; Recurrent cancer; Residual cancer; Tongue cancer

Indexed keywords

CESIUM 137; GOLD 198; IRIDIUM 192; RADON;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE CARE; QUALITY OF LIFE; RADIATION DOSE; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SCORING SYSTEM; TONGUE CANCER;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS;

EID: 33847663706     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1613-5     Document Type: Article

References (32)

1. Barret WL, Gleich L, Wilson K, et al. Organ preservation with interstitial radiation for base of tongue cancer. Am J Clin Oncol 2002;25:485-8.
2. Chao KS, Emami B, Akhileswaren R, et al. The impact of surgical margin status and use of an interstitial impact in T1, T2 oral tongue cancers after surgery. Int J Radiat Oncol Biol Phys 1996; 36:1039-43.
3. De Crevoisier R, Bourhis J, Domenge C, et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-62.
4. Dietl B, Schäfer C, Kölbl O. [The prognostic value of time parameters in adjuvant radiotherapy of head and neck cancer. A retrospective analysis of 138 patients.] Strahlenther Onkol 2005;182:800-7, discussion 808-9.
5. Fujita M, Hirokawa Y, Kashiwado K, et al. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 1996;34:333-9.
6. Gerhard G, Claus R, Thomas B, et al. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Strahlenther Onkol 2001;177:338-44.
7. Ichimiya Y, Fuwa N, Kamata M, et al. Treatment results of stage I oral tongue cancer with definitive radiotherapy. Oral Oncol 2005;41:520-5.
8. Ihara N, Shibuya H. Yoshimura R, et al. Interstitial brachytherapy and neck dissection for stage III squamous cell carcinoma of the mobile tongue. Acta Oncol 2005;44:709-16.
9. Kovacs AF, Mose S, Böttcher HD, et al. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol 2005;182:26-34.
10. Krull A, Friedrich RE, Schwarz R, et al. Interstitial high dose brachytherapy in locally progressive or recurrent head and neck cancer. Anticancer Res 1999;19:2695-8.
11. Lapeyre M, Hoffstetter S, Peiffert D, et al. Postoperative brachytherapy alone for T1-2N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 2000;48:37-42.
12. Leung TW, Lee AW, Chan DK. Definitive radiotherapy for carcinoma of the oral tongue. Acta Oncol 1993;32:559-64.
13. Lozza L, Cerrotta A, Gardani G, et al. Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer. Radiother Oncol 1997;44:143-7.
14. Mazeron JJ, Crook JM, Benck V, et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990;19:1369-76.
15. Mazeron JJ, Langlois D, Glaubiger D, et al. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int J Radiot Oncol Biol Phys 1987;13:957-62.
16. Miura M, Takeda M, Sasaki T, et al. Factors affecting mandibular complication in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys 1998;41:763-70.
17. Moore GJ. Quality of life after radiation therapy for base of tongue cancer. Oncology 1996;10:1643-8.
18. Nose T, Peiffert D, Lapeyre M, et al. Late effect of post-high-dose-rate brachytherapy for oropharyngeal carcinoma. Strahlenther Onkol 2004;180:776-82.
19. Pomp J, Levendag PC, van Putten WL. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 1998;11:543-9.
20. Salz H, Wiezorek T, Scheithauer M, et al. IMRT with compensators for head-and-neck cancers. Treatment technique, dosimetric accuracy, and practical experiences [Erratum in: Strahlenther Onkol 2005;181:810]. Strahlenther Onkol 2005;181:665-72.
21. Shibuya H, Hoshina M, Takeda M, et al. Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complication. Int J Radiat Oncol Biol Phys 1993;26:51-8.
22. Sparano A, Weinstein G, Chalian A, et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 2004;131:472-6.
23. Spencer SA, Wheeler RH, Peter GE, et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 1999;22:1-5.
24. Strnad V, Melzner W, Geiger M, et al. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients. Strahlenther Onkol 2005;181:762-7.
25. Sun LM, Leung SW, Su CY, et al. The relapse patterns and outcome of postoperative recurrent tongue cancer. J Oral Maxillofac Surg 1997;55:827-31.
26. Takacsi-Nagy Z, Polgar C, Oberna F, et al. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Strahlenther Onkol 2004;180:768-75.
27. Umeda M, Komatsubara H, Nishimatsu N, et al. High-dose rate interstitial brachytherapy for stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:667-70.
28. Umeda M, Komatsubara H, Ojima Y, et al. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 2005;34:739-44.
29. Veness MJ, Morgan GJ, Sathivaseelan Y, et al. Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? Aust N Z J Surg 2005;75:101-5.
30. Vratislav S. Treatment of oral cavity and oropharyngeal cancer. Strahlenther Onkol 2004;180:710-7.
31. Wang CC, McIntyre J. Re-irradiation of laryngeal carcinoma - techniques and results. Int J Radiat Oncol Biol Phys 1993;26:783-5.
32. Yamazaki H, Inoue T, Yoshida K, et al. Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiat Oncol Biol Phys 2004;58:139-46.